Ayse N. Menevse
Regensburg, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
IL-2 and TCR stimulation induce expression and secretion of IL-32β by human T cells.
Journal: Frontiers in immunology
Published: May 23, 2024
Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages.
Journal: Acta neuropathologica communications
Published: June 26, 2023
Depletion of preexisting B-cell lymphoma 2-expressing senescent cells before vaccination impacts antigen-specific antitumor immune responses in old mice.
Journal: Aging cell
Published: June 05, 2023
The effector program of human CD8 T cells supports tissue remodeling.
Journal: The Journal of experimental medicine
Published: March 21, 2023
TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastoma.
Journal: Acta neuropathologica communications
Published: February 07, 2023
Low-density lipoprotein balances T cell metabolism and enhances response to anti-PD-1 blockade in a HCT116 spheroid model.
Journal: Frontiers in oncology
Published: November 25, 2022
Salt-inducible kinase 3 protects tumor cells from cytotoxic T-cell attack by promoting TNF-induced NF-κB activation.
Journal: Journal for immunotherapy of cancer
Published: April 29, 2022
Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8.
Journal: Science advances
Published: March 23, 2022
Differential localization of PD-L1 and Akt-1 involvement in radioresistant and radiosensitive cell lines of head and neck squamous cell carcinoma.
Journal: Carcinogenesis
Published: August 28, 2019
CAMK1D Triggers Immune Resistance of Human Tumor Cells Refractory to Anti-PD-L1 Treatment.
Journal: Cancer immunology research
Published: August 08, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026